Does a minimal invasive approach reduce anterior chest wall XXXX and @entity282 in plate fixation of @entity174 ?

@entity1 @entity1183 @entity1538 @entity174 @entity2850 @entity158 @entity282
BACKGROUND: Fractures of the clavicle present very common injuries with a peak of incidence in young active @entity1 . Recently published randomized clinical trials demonstrated an improved functional outcome and a lower rate of nonunions in comparison to non-operative treatment. Anterior chest wall @entity1183 due to @entity282 constitute common surgery related complications in plate fixation of displaced @entity174 . We recently developed a technique for mini open plating (MOP) of the clavicle to reduce postoperative @entity1183 and @entity158 . The purpose of this study was to analyze the size of anterior chest wall @entity1183 and the intensity of @entity282 in MOP in comparison to @entity1538 ( @entity1538 ) of @entity174 . METHODS: 24 @entity1 (mean age 38.2    14.2 yrs.) with a displaced @entity174 of the clavicle (Orthopaedic Trauma Association B1.2-C1.2) surgically treated using a @entity2850 ( @entity2850 ) were enrolled. 12 @entity1 underwent MOP and another 12 @entity1 @entity1538 . Anterior chest wall @entity1183 was measured with a transparency grid on the second postoperative day and at the six months follow-up. @entity282 was evaluated using the Visual Analog Scale (VAS). RESULTS: Mean ratio of skin incision length to plate length was 0.61    0.04 in the MOP group and 0.85    0.06 in the @entity1538 group (p < 0.05). Mean ratio of the area of anterior chest wall @entity1183 to plate length was postoperative 7.6    5.9 (six months follow-up 4.7    3.9) in the MOP group and 22.1    19.1 (16.9    14.1) in the @entity1538 group (p < 0.05). Mean VAS was 2.6    1.4 points in the MOP group and 3.4    1.6 points in the @entity1538 group (p = 0.20). CONCLUSIONS: In our study, MOP significantly reduced anterior chest wall @entity1183 in comparison to a conventional open approach postoperative as well as at the six months follow-up. @entity282 tended to be lower in the MOP group, however this difference was not statistically significant. TRIAL REGISTRATION: ClinicalTrials.gov NCT02247778 . Registered 21 September 2014.
